| ²é¿´: 1786 | »Ø¸´: 4 | |||
zdr117Òø³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿¹ØÓÚÃÀ¹úBBI¹«Ë¾ÑªÇåÅ̺ͱê׼Ʒ ÒÑÓÐ4È˲ÎÓë
|
| ¹«Ë¾Óû¹ºÂò¹ØÓÚÃÀ¹úBBI¹«Ë¾ÑªÇåÅ̺ͱê׼Ʒ£¬¸÷λËÓиù«Ë¾µÄ²úÆ·Ïà¹Ø×ÊÁϺÍÈçºÎ¹ºÂò£¬Íû¹²Ïí£¡£¡ |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸C9µÄ»¯Ñ§¹¤³Ì£¨085602£© 340·Ö£¬¸Ð¾õУÄÚµ÷¼ÁÎÞÍû£¬Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Öйú¹Å½¨Öþͼ½â£¨²ÊÉ«£©¡¢Öйú¹Å½¨Öþͼµä 115ÍøÅÌ
ÒѾÓÐ12È˻ظ´
WIN7Ó²ÅÌÔõô½øÐзÖÇø£¬Ôõôϵͳ±¸·Ý£¿
ÒѾÓÐ5È˻ظ´
¹ØÓÚÀë×ÓÒºÌåÒõÑôÀë×ӵĽâÀëÎÊÌ⣬¹Ø¼üÖ®ËùÔÚ°¡¡£¡£¡£¡£
ÒѾÓÐ9È˻ظ´
¡¾½»Á÷¡¿¹ØÓÚ6005ÂÁºÏ½ðµÄ¸¯Ê´Ð§¹û
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿¹ØÓÚÓÃÊäÒº¹Ü½øÐеμӷ´Ó¦ÎïµÄÎÊÌâ
ÒѾÓÐ10È˻ظ´
Óиö¹ØÓÚ´ýͶ¸åÂÛÎĵÄ×÷ÕßÎÊÌâ¡£
ÒѾÓÐ13È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿´ó¼ÒÖªµÀÄÄЩ¹«Ë¾¿ÉÒԺϳÉЩ³ý²Ý¼Á´úлÎï±ê׼Ʒ£¿
ÒѾÓÐ4È˻ظ´

ÓÖ²»Öª²»¾õ
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
´¿´¿¼Ò×åÃØÊé
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 1.371
- ½ð±Ò: 3102.2
- É¢½ð: 819
- ºì»¨: 15
- ɳ·¢: 10
- Ìû×Ó: 13944
- ÔÚÏß: 145.7Сʱ
- ³æºÅ: 635530
- ×¢²á: 2008-10-24
- ÐÔ±ð: MM
- רҵ: »·¾³ÎÛȾ»¯Ñ§
- ¹ÜϽ: ¹«ÎñÔ±¿¼ÊÔ

2Â¥2010-05-28 10:17:04
liyong1981
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 774.1
- É¢½ð: 116
- Ìû×Ó: 905
- ÔÚÏß: 35.2Сʱ
- ³æºÅ: 357405
- ×¢²á: 2007-04-27
- ÐÔ±ð: GG
- רҵ: antibody
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
BBI²»ÊÇÉϺ£Éú¹¤ÔÚ¼ÓÄôó×Ô¼º×¢²áµÄÒ»¸ö¼ÙÑó¹í×ÓÆóÒµÂð£¿ÃÀ¹úÒ²ÓУ¿ |
3Â¥2010-05-28 10:34:01
jasco
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 17 (СѧÉú)
- ½ð±Ò: 1626.1
- ºì»¨: 3
- Ìû×Ó: 991
- ÔÚÏß: 82Сʱ
- ³æºÅ: 287776
- ×¢²á: 2006-10-21
- רҵ: ÉúÎﻯѧ
4Â¥2010-05-28 13:38:20
Íøº£Ò»ÓÎ
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1219.5
- Ìû×Ó: 204
- ÔÚÏß: 1.1Сʱ
- ³æºÅ: 239404
- ×¢²á: 2006-04-06
- רҵ: ¿¹Ì幤³Ìѧ
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
| Headquartered in the United Kingdom, BBI Holdings Plc, an Alternative Investment Market listed company is a leading supplier of products and services to the global diagnostic and healthcare industries. (note: "BBI" = British Biocell International) The company¡¯s core activities include the production of gold reagents, contract research and development, and manufacture of rapid diagnostic tests for the Point of Care (POC) markets. In the Madison site, established in 2005, BBI Research Inc. offers new product development services for lateral flow diagnostics to the US market and allows the servicing of far reaching geographical markets. |
5Â¥2012-03-15 11:27:01














»Ø¸´´ËÂ¥